Product Highlight - Firazyr

30 Nov 2021
Product Highlight - Firazyr
Active ingredient: Icatibant acetate.

Indication: Symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adolescents & children aged ≥2 years, w/ C1-esterase-inhibitor deficiency.

Dosage & Administration: 30 mg as single subcutaneous injection.

Related MIMS Drugs

Editor's Recommendations